Bill Gates Germany covid-19 RNA vaccine Bill Gates Germany

CureVac doesn't rule out accelerated approval for Covid-19 vaccine

Reading now: 613
www.livemint.com

FRANKFURT: German biotechnology firm CureVac does not rule out a speedy approval process for its prospective vaccine against Covid-19, its chief executive was quoted as saying on Sunday.The company said on Friday that it expects to put its vaccine on the market by mid-2021.

Obtaining speedy approval suggests the company is pushing for an earlier release date although CEO Franz-Werner Haas did not give any details on how likely this was."We are not ruling out accelerated approval, but this can only be achieved in close cooperation with the authorities," Haas told the Boerse Online financial website.CureVac, backed by Microsoft founder and billionaire Bill Gates, listed on the Nasdaq stock market on Friday, raising $213 million.The results of.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA